Illumina to release TruSight Oncology 500 v2
DNA technology company Illumina is due to release TruSight Oncology 500 v2 (TSO 500 v2), a new version of its cancer research essay to enable comprehensive genomic profiling (CGP). “There are different needs for biomarker profiling, and Illumina has …